Largescale multicenter study of a serum metabolite biomarker panel for the diagnosis of breast cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Largescale multicenter study of a serum metabolite biomarker panel for the diagnosis of breast cancer

Published:2024-07 Issue:7 Volume:27 Page:110345
ISSN:2589-0042
Container-title:iScience
language:en
Short-container-title:iScience

Author:

Wang Yanzhong,An Rui,Yu Haitao,Dai Yuehong,Lou Luping,Quan Sheng,Chen Rongchang,Ding Yanjun,Zhao Hongcan,Wu Xuanlan,Liu Zhen,Wang Qinchuan,Gao Yuzhen,Xie Xinyou,Zhang Jun

Funder

National Natural Science Foundation of China

Key Research and Development Program of Zhejiang Province

Publisher

Elsevier BV

Reference46 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries;Sung;CA. Cancer J. Clin.,2021

2. Global patterns of breast cancer incidence and mortality: A population-based cancer registry data analysis from 2000 to 2020;Lei;Cancer Commun.,2021

3. Cancer incidence and mortality in China, 2022;Han;J. Natl Cancer Center,2024

4. A nation-wide multicenter 10-year (1999-2008) retrospective clinical epidemiological study of female breast cancer in China;Li;BMC Cancer,2011

5. Epidemiology and clinicopathologic features of breast cancer in China and the United States;Qian;Transl. Cancer Res.,2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP